Which generation of targeted drug is Asiminib?

Asciminib (scemblix/asciminib) is a second-generation targeted drug. Asciminib is a BCR-ABL tyrosine kinase inhibitor. Aximinibis a targeted therapy that works by specifically targeting the ABLmyristoyl pocket (STAMP ), a site of action that is different from other kinase inhibitors.

Asciminib(scemblix/asciminib) is a kinase inhibitor used to treat adult patients with the following:Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in the chronic phase (CP), previously treated with two or more tyrosine kinase inhibitors (TKIs) and T315Imutated chronic myelogenous leukemia Ph+chronic myelogenous leukemia.

Sometimes it is unsafe to use certain drugs together. Some medicines can affect the blood levels of other medicines you take, which may increase side effects or make the medicine less effective. Tell your doctor about all the medicines you take, including prescription drugs, over-the-counter drugs, vitamins, and herbal supplements. Asiminib may harm your unborn baby and your doctor will perform a pregnancy test before starting treatment. Females who may become pregnant should use effective contraception during treatment and for one week after the last dose. Askyour doctorabout suitable contraceptive methods. If you become pregnant unexpectedly during treatment or think you may be pregnant, tellyour doctor right away. It is unknown whether asiminib passes into breast milk, do not breastfeed during treatment and for 1 week after the last dose. The retail price of Lucius Pharmaceuticals in Laos40mg60tablets4more than a thousand. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0

xa0